Leaderboard

En | De
No articles selected!     View Cart  
You are here: Respiratory Tract » Interstitial Lung Diseases 27. January 2026
Search
medline.ch
Interstitial Lung Diseases
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Allergic Rhinitis - Hay Fever
Asthma
Bronchitis
COPD
Interstitial Lung Diseases
Pulmonary Embolism
Neoplasms
Pleural Diseases
Pneumonia
SARS
Sleep Apnoe Disorder
Tuberculosis
Cystic Fibrosis
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 1969  Previews Next
   
   Articles 1 - 20 / 39378  
   
Study on the mechanism of anti-pulmonary fibrosis action of Jingfang granules based on the Keap1-Nrf2-GPX4 pathway.
J Ethnopharmacol
Yu W, Chen Y, Chen H, Jiang Z, Yao J, Li S, Zhang G, Li X.
PMID: 41581793 [PubMed - as supplied by publisher]


Predictors of Disease Progression in Idiopathic Pulmonary Fibrosis Under Antifibrotic Therapy: A Retrospective Study.
Cureus
Kishaba T, Higa M, Nagano H.
PMID: 41573428 [PubMed]


Protective role of natural products in pulmonary fibrosis through immuneregulation.
Chin J Nat Med
Su Y, Che X, Chen Y, Wu X, Wang J, Jiang Z, Li X.
PMID: 41571364 [PubMed - indexed for MEDLINE]


Antifibrotic therapy and lung cancer risk in patients with idiopathic pulmonary fibrosis: a large retrospective propensity-weighted cohort study.
Thorax
Kijlertsuphasri S, Petnak T, Moua T.
PMID: 41571308 [PubMed - as supplied by publisher]


Oral Nalbuphine in Idiopathic Pulmonary Fibrosis-Associated Cough: The CORAL Randomized Clinical Trial.
JAMA
Molyneaux PL, Mogulkoc N, Gunen H, Doboszynska A, Kreuter M, Neustifter B, Mathur V, Cassella J, CORAL Study Group.
PMID: 41569557 [PubMed - as supplied by publisher]


The effect and safety of small-molecule antiviral drugs on long prognosis of post-COVID-19 pulmonary fibrosis: a real-world study in China.
Front Microbiol
Xu Y, Lu M, Li Y, Den X, Peng D, Zhou F, Li A, Hou T, Xiang T.
PMID: 41568045 [PubMed]


Advances in the research and application of stem cell therapies for idiopathic pulmonary fibrosis.
Am J Clin Exp Immunol
Xu L, Hou X, Zhou X, Jiang M.
PMID: 41567723 [PubMed]


Association between enteral feeding guideline implementation and early enteral nutrition in children with critical bronchiolitis: An uncontrolled before-after study.
JPEN J Parenter Enteral Nutr
Huq S, Pareek R, Knapp K, Mikhailov T.
PMID: 41566998 [PubMed - as supplied by publisher]


Reply: Comment on "New insights from mendelian randomization and mediation analysis: causal relationships between mitochondrial DNA copy number and telomere length in pulmonary fibrosis".
QJM
Li Y, Hou L.
PMID: 41565371 [PubMed - as supplied by publisher]


Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype.
Adv Respir Med
Dagher C, Thomas A, Al Absi S, Carollo B, Fiscus G, Parikh R.
PMID: 41562965 [PubMed - indexed for MEDLINE]


Treatment Adherence and Persistence of Anti-Fibrotic Drugs in Real Life in Greece.
Adv Respir Med
Kourlaba G, Ravanidis S, Stefanou G, Mathioudakis K, Tsolakidis A, Zografopoulos D.
PMID: 41562964 [PubMed - indexed for MEDLINE]


Ravulizumab in NMOSD with associated interstitial pneumonitis in a 59-year-old female patient: a case report.
Front Immunol
Neundorf A, Dittrich R.
PMID: 41562061 [PubMed - indexed for MEDLINE]


Nintedanib for progressive pulmonary fibrosis in real-world setting: an observational study comparing outcomes with an IPF cohort.
BMC Pulm Med
Muscato G, Libra A, Reina C, Gili E, Fruciano M, Martella S, Palmucci S, Spicuzza L, Sambataro G, Vancheri C.
PMID: 41559703 [PubMed - as supplied by publisher]


Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS study.
BMJ Open Respir Res
Khan F, Stewart I, Howard L, Barber CM, Borton R, Braybrooke R, Hearson G, Jones S, Maher T, Matthews L, Saini G, Thompson N, Wilson AM, Johnson SR, Jenkins G.
PMID: 41558800 [PubMed - indexed for MEDLINE]


Patient-reported experience measure (PREM) for patients with interstitial lung disease (ILD): modification of a pre-existing measure.
BMJ Open Respir Res
Mandizha J, Crook C, Lanario J, Davies R, Duckworth A, Almond HP, Lines S, Gibbons M, Scotton C, Russell AM.
PMID: 41558799 [PubMed - indexed for MEDLINE]


Assessment of Sleep-Disordered Breathing and Sleep Quality in Childhood Interstitial Lung Disease: A Single-Center Experience.
Pediatr Pulmonol
Oksay SC, Ülgen Ö, Öztürk Y, Ça, Gürler E, Polat ZB, Akdulum , Girit S.
PMID: 41555791 [PubMed - indexed for MEDLINE]


Epidemiology of idiopathic pulmonary fibrosis: a population registry-based study.
Orphanet J Rare Dis
Francesca G, Michele S, Anna P, Paolo C, Davide C, Federico L, Francesco P, Elisabetta R, Laura T, Sara T, Carrozzi L, Elena B, Alessio C.
PMID: 41555350 [PubMed - as supplied by publisher]


Qingzao Jiufei Decoction in the Regulation of TGF-β/Smad Signaling in Idiopathic Pulmonary Fibrosis.
J Vis Exp
Du Y, Jiao T, Ma W, Zhou B, Niu Y, Mao C.
PMID: 41553967 [PubMed - indexed for MEDLINE]


The role of immune cell crosstalk and signaling pathways in the pathogenesis of pulmonary fibrosis.
Mol Biol Rep
Liu X, Chen H, Guo C, Lin Y, Wang F, Lan Z.
PMID: 41553576 [PubMed - in process]


Monocyte-mediated mechanisms in idiopathic pulmonary fibrosis: opportunities for early intervention.
Apoptosis
Mao Z, Liu Y, Han C, Yang X, Lin X, Tian S, Miao M.
PMID: 41553566 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 39378    Page 1 of 1969  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1